Renal denervation (RDN)

Find all the latest content on renal denervation (RDN) published on this website.

Despite the existence of effective antihypertensive drugs, arterial hypertension remains a critical challenge for healthcare systems worldwide. Can catheter-based renal denervation (RDN) play an effective part in reducing, previously untreatable high blood pressure? Follow the latest research in this novel field along with the critical issues of blood pressure monitoring, imaging modalities, tools, devices and techniques as well as vascular access, bleeding risk and adjunctive pharmacotherapy…

Filtered By
Renal denervation

93 results

Successful implementation of renal denervation in hypertension management (the hardest part is getting started)

16 May 2024 – From EuroPCR 2024

This session provides a comprehensive guide on setting up a successful renal denervation program. It covers topics such as identifying the ideal patients for this therapy, integrating patient preferences in decision-making, the necessary workup process, and the procedural aspects of renal denervation. The session also features...

Successful implementation of renal denervation in hypertension management (the hardest part is getting started)

The turning point in hypertension care: Symplicity Spyral renal denervation in practice

15 May 2024 – From EuroPCR 2024

Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...

The turning point in hypertension care: Symplicity Spyral renal denervation in practice

Clinical adoption of renal denervation: no more excuses

15 May 2024 – From EuroPCR 2024

Clinical adoption of renal denervation: no more excuses

Renal interventions

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on renal interventions. It will cover various topics, including a novel approach to handle renal artery stenoses, an interesting case of paroxysmal nocturnal dyspnoea, accessory arteries in renal denervation and OCT, as well as renal denervation...

Renal interventions

First-in-man and out-of-the-box innovations hotline

15 May 2024 – From EuroPCR 2024

This session showcases a variety of first-in-man and innovative technologies in the field of interventional cardiology. Presentations will cover topics such as NeuroOCT (nOCT) for intracranial imaging, the BackBeat system for atrio-ventricular interval modulation, renal stimulation with direct wire pacing, the TIVUS system for renal denervation,...

First-in-man and out-of-the-box innovations hotline

Renal denervation step by step: how to perform a safe and effective procedure

14 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...

Renal denervation step by step: how to perform a safe and effective procedure

Innovations in renal denervation: deja vu or reality?

13 May 2024 – From EuroPCR 2024

Innovations in renal denervation: deja vu or reality?

PCRonline @ ACC.24 Scientific Sessions

22 Mar 2024

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24

PCRonline @ ACC.24 Scientific Sessions

Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive drugs: 3-month primary results from the TARGET BP I Randomized Trial

08 Apr 2024

Alessandro Sticchi interviews David E. Kandzari about the results of the Target Bp I Randomized Trial which he presented at ACC.24.

The trial reports mixed results on nerve ablation for high blood pressure with a modest but statistically significant difference in lowered blood pressure at 3 months,...

David Kandzari

Author

David Kandzari
Alessandro Sticchi

Author

Alessandro Sticchi
Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive drugs: 3-month primary results from the Target Bp I Randomized Trial

Renal denervation 2.0 - Ready for clinical use?

06 Dec 2023 – From GulfPCR-GIM 2023

Stay updated on the latest clinical evidence, guidelines, and technology related to renal denervation. Engage in discussions about the clinical experiences with ultrasound renal denervation (uRDN) and gain practical insights into selecting patients through real-world cases.

Renal denervation 2.0 - Ready for clinical use?